LBA3 Enzalutamide in men with chemotherapy-naive metastatic castration resistant prostate cancer (MCRPC): Primary and European regional results of the phase 3 prevail study

B Tombal, P Iversen, K Miller, T Tammela, Michael Borre, A Bjartell, P Mulders, J Kliment, J Ramon, V Matveev

    Original languageEnglish
    JournalEuropean Urology Supplements
    Issue number1
    Pages (from-to)LBA3
    Publication statusPublished - 2014

    Cite this